SENS Stock Summary and Trading Ideas (Senseonics Holdings | NASDAQ:SENS)

Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.

Senseonics Holdings trades on the NASDAQ stock market under the symbol SENS.

As of January 21, 2026, SENS stock price climbed to $7.23 with 349,236 million shares trading.

SENS has a beta of 2.32, meaning it tends to be more sensitive to market movements. SENS has a correlation of 0.22 to the broad based SPY ETF.

SENS has a market cap of $295.41 million. This is considered a Small Cap stock.

Last quarter Senseonics Holdings reported $8 million in Revenue and -$.43 earnings per share. This beat revenue expectation by $160,402 and missed earnings estimates by -$.06.

In the last 3 years, SENS traded as high as $28.00 and as low as $5.00.

The top ETF exchange traded funds that SENS belongs to (by Net Assets): VTI, VXF, SCHA, ITOT, SCHB.

SENS has underperformed the market in the last year with a return of -57.4%, while the SPY ETF gained +15.9%. In the last 3 month period, SENS fell short of the market, returning -14.6%, while SPY returned +2.4%. However, in the most recent 2 weeks SENS has outperformed the stock market by returning +14.8%, while SPY returned -0.9%.

SENS support price is $6.80 and resistance is $7.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SENS shares will trade within this expected range on the day.